Consumer Goods » Cosmetics & Personal Care Products | Boryung Medience Co. Ltd.

Boryung Medience Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
8,256
11,531
5,191
13,420
13,620
Total Accounts Receivable
22,394
23,688
19,450
17,030
16,055
Inventories
22,714
21,815
20,143
22,059
21,476
Other Current Assets
1,019
532
767
913
524
Total Current Assets
54,383
57,566
45,551
53,422
51,675
Net Property, Plant & Equipment
13,540
13,476
22,789
21,690
22,227
Total Investments and Advances
11,975
13,719
17,697
16,607
20,421
Long-Term Note Receivable
848
-
2,257
-
-
Intangible Assets
1,137
898
1,224
2,106
1,818
Other Assets
1,009
131
122
1,175
1,051
Total Assets
85,966
87,913
91,803
97,597
99,120
ST Debt & Current Portion LT Debt
20,425
16,482
11,899
18,748
17,157
Accounts Payable
9,090
10,279
8,704
8,769
8,794
Income Tax Payable
256
422
791
2,042
884
Other Current Liabilities
13,692
14,011
14,551
14,663
12,457
Total Current Liabilities
43,463
41,195
35,944
44,222
39,293
Long-Term Debt
3,900
3,575
6,925
5,275
6,125
Provision for Risks & Charges
4,082
4,096
4,057
4,173
4,575
Deferred Taxes
3,074
2,123
2,163
2,597
1,928
Other Liabilities
3,071
2,219
2,412
2,326
1,943
Total Liabilities
54,516
51,085
49,338
55,995
51,937
Common Equity (Total)
31,450
36,829
42,464
41,602
47,183
Total Shareholders' Equity
31,450
36,829
42,464
41,602
47,183
Total Equity
31,450
36,829
42,464
41,602
47,183
Liabilities & Shareholders' Equity
85,966
87,913
91,803
97,597
99,120

About Boryung Medience Co.

View Profile
Address
Boryung Building
Seoul SL 03127
Korea, Republic Of
Employees -
Website http://www.medience.co.kr
Updated 09/14/2018
Boryung Medience Co., Ltd. engages in the manufacture and sale of clinical and scientific products for infants. The firm offers its products under the B&B, Dr. ato, The Pure, ONO2, MUAA, KOTT, Tartine et Chocolat, CRITEM, SKIPHOP, BEABA, Yookidoo, nomi, BBhouse, Cradle to Cradle, and I.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.